Quick answer
Lion's mane has roughly ten small human studies and one early finding, in adults over 50 at about 3 g a day of fruiting body powder. Chaga has no trial in people. On labels, lion's mane names the part and a polysaccharide percentage, while our Mushroom Complex does not print chaga's share.1,2,3,4
Key facts
- Lion's mane trials with a result gave about 3 g a day of fruiting body powder. No trial has set an amount for chaga.1,4,5
- A polysaccharide percentage on a label is not a beta-glucan figure, because starch counts as a polysaccharide too.6
- Chaga powders from three companies held 2.8, 11.2 and 14.2 g of oxalate per 100 g.4
- Problems reported in lion's mane trials were mostly mild stomach complaints in under 10% of people. The chaga reports are of kidney damage.7,8
The two, side by side
| Chaga | Lion's mane | |
|---|---|---|
| Scientific name | Inonotus obliquus | Hericium erinaceus |
| How it is sold | Powder, tea and extracts | An edible mushroom eaten fresh in East Asia, also sold as powder and extract |
| Part used where studied | No trial of chaga alone | Fruiting body powder in the trials with a difference; a cultured mycelium in one 49-week trial |
| Human studies | None of chaga alone | Roughly ten small ones |
| Best graded finding | None | One, graded early, in adults over 50 |
| Reported problems | Kidney damage after daily powder for months or years | Mild stomach complaints in under 10% of people; one severe lung reaction in one man |
| Label detail to look for | Grams of powder a day, since the kidney cases tracked daily grams | Which part is used, the amount, and what a polysaccharide percentage covers |
What a label can and cannot tell you
Our Lion's Mane label names the part of the mushroom, a fruiting body and mycelium powder, gives 1,000 mg a serving and says it is standardized to 40% polysaccharides, which is 400 mg. That tells you the amount and the part. It does not give a beta-glucan figure.6
Starch is a polysaccharide too, so a total polysaccharide figure on a label is not the same as beta-glucan. Beta-glucan tests measure total glucan and subtract starch and glycogen, which are measured separately.6
The chaga row in our Mushroom Complex is a different case. Chaga is named among six mushrooms in a shared 266 mg blend, with no amount for each. For chaga the amount is what matters, since the published kidney cases tracked grams of powder taken daily, so a label that leaves it out leaves the main question open.4
What each has shown in people
Lion's mane has one graded finding. It was seen in adults over 50, and trials in younger adults gave mixed or null results.
May support memory and thinking test scores in adults over 50 at about 3 g a day of fruiting body powder; not shown in younger adults*1,5,11,12,13
Early evidence
Two small Japanese trials. In 30 adults aged 50 to 80 whose memory and thinking had been assessed as mildly below normal for their age, about 3 g a day of fruiting body powder for 16 weeks raised scores on a cognitive scale more than placebo at weeks 8, 12 and 16, and the gain faded within 4 weeks of stopping. In 31 adults over 50, 3.2 g a day for 12 weeks gave a slightly higher result than placebo on one screening test and no difference on two others. In younger adults, 10 g a day for 4 weeks changed nothing measured, and single doses of 1 to 3 g gave mixed results.
Amount studied: About 3 to 3.2 g a day of fruiting body powder for 12 to 16 weeks
Single-dose trials in healthy adults under 50 gave mixed results: a faster time on one attention task an hour after 1.8 g, alongside fewer words recalled; small changes from each person's own starting point after 1 g; and no overall change after 3 g of extract.12,13,14
Chaga has no graded finding. We found no trial of chaga on its own in people, only an herb mixture that was one fifth chaga and a test on blood cells in a dish.3,15
Fruiting body, mycelium and powder
The mycelium is the network of threads the mushroom grows from. For supplements it is grown in culture, for example in liquid tanks, and it is the source of erinacines.9,13,16
A 2025 trial paper states that lion's mane mycelium preparations are not allowed in foods or supplements in the EU and UK, while fruiting body extracts are.13
Chaga is sold as a ground powder, and every published case of kidney damage involved chaga powder taken daily.4,8,17
The word mushroom on a bottle can therefore mean quite different things. For lion's mane, the part decides which trials apply to a product. For chaga, the form decides which case reports apply, and every published case of kidney damage involved powder rather than an extract.4,8,16,17
What's in ours
Our Lion's Mane gives 1,000 mg of lion's mane powder and has no other ingredient row. Our Mushroom Complex gives 266 mg of lion's mane and holds chaga in its shared blend row. The roughly 3 g a day in the lion's mane trials is three times the first and more than ten times the second, and we make no claim for chaga in either.1
Kidney, stomach and who should ask first
Oxalate nephropathy, kidney damage from oxalate crystals, has been reported in at least three people who took chaga powder every day for months or years.4,8,17
No upper limit or safe daily amount has been set for chaga. In the reports that gave amounts in grams, people with kidney damage took 3 to 15 g of powder a day, for 3 months to 5 years.4,8
Stomach discomfort, nausea or diarrhea, reported by under 10% of people in longer trials.7,9
Skin rash. In a 49-week trial, 3 people taking lion's mane stopped because of stomach discomfort, nausea or a rash, against 1 on placebo who stopped because of nausea.9
- Do not take chaga if you have kidney disease or have had kidney stones, unless your kidney doctor agrees4
- Ask first about chaga if you take vitamin C supplements, or have taken chaga every day for months8
- Ask first about either if you take a blood thinner or antiplatelet medicine, or have surgery planned: a chaga peptide and a lion's mane compound both slowed platelet clumping in laboratory tests18,19
- Do not take lion's mane if you have had an allergic reaction to it or to another mushroom2,10
- Ask first if you are pregnant or breastfeeding, being treated for cancer, or under 18
Questions people ask
Which has more research, chaga or lion's mane?
Lion's mane, by a wide margin: roughly ten small studies in people, against none of chaga on its own. Even so, lion's mane has only one graded finding, and it is early.1,2,3
See what we make
Every product shows its whole label and what its lab report covers. The store opens soon.
Sources
- Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-372. Opened 2026-10-07.
- Menon A, Jalal A, Arshad Z, Nawaz FA, Kashyap R. Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. Front Nutr. 2025;12:1641246. Opened 2026-10-07.
- Hong YH. Effects of the herb mixture, DTS20, on oxidative stress and plasma alcoholic metabolites after alcohol consumption in healthy young men. Integr Med Res. 2016;5(4):309-316. Opened 2026-10-07.
- Lee S, Lee HY, Park Y, Ko EJ, Ban TH, Chung BH, Lee HS, Yang CW. Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature. J Korean Med Sci. 2020;35(19):e122. Opened 2026-10-07.
- Saitsu Y, Nishide A, Kikushima K, Shimizu K, Ohnuki K. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res. 2019;40(4):125-131. Opened 2026-10-07.
- McCleary BV, Draga A. Measurement of beta-glucan in mushrooms and mycelial products. J AOAC Int. 2016;99(2):364-373. Opened 2026-10-07.
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Lion's Mane. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Last update January 5, 2024. Opened 2026-10-01.
- Kwon O, Kim Y, Paek JH, Park WY, Han S, Sin H, Jin K. Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report. Medicine (Baltimore). 2022;101(10):e28997. Opened 2026-10-07.
- Li IC, Chang HH, Lin CH, et al. Prevention of early Alzheimer's disease by erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study. Front Aging Neurosci. 2020;12:155. Opened 2026-10-07.
- Nakatsugawa M, Takahashi H, Takezawa C, et al. Hericium erinaceum (yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins. Intern Med. 2003;42(12):1219-1222. Opened 2026-10-07.
- Grozier CD, Alves VA, Killen LG, Simpson JD, O'Neal EK, Waldman HS. Four weeks of Hericium erinaceus supplementation does not impact markers of metabolic flexibility or cognition. Int J Exerc Sci. 2022;15(2):1366-1380. Opened 2026-10-07.
- Docherty S, Doughty FL, Smith EF. The acute and chronic effects of lion's mane mushroom supplementation on cognitive function, stress and mood in young adults: a double-blind, parallel groups, pilot study. Nutrients. 2023;15(22):4842. Opened 2026-10-07.
- Surendran G, Saye J, Binti Mohd Jalil S, et al. Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study. Front Nutr. 2025;12:1405796. Opened 2026-10-07.
- La Monica MB, Raub B, Ziegenfuss EJ, et al. Acute effects of naturally occurring guayusa tea and Nordic lion's mane extracts on cognitive performance. Nutrients. 2023;15(24):5018. Opened 2026-10-07.
- Najafzadeh M, Reynolds PD, Baumgartner A, Jerwood D, Anderson D. Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease. Biofactors. 2007;31(3-4):191-200. Opened 2026-10-07.
- Li IC, Chen YL, Lee LY, et al. Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague-Dawley rats. Food Chem Toxicol. 2014;70:61-67. Opened 2026-10-07.
- Kikuchi Y, Seta K, Ogawa Y, Takayama T, Nagata M, Taguchi T, Yahata K. Chaga mushroom-induced oxalate nephropathy. Clin Nephrol. 2014;81(6):440-444. Opened 2026-10-07.
- Hyun KW, Jeong SC, Lee DH, Park JS, Lee JS. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides. 2006;27(6):1173-1178. Opened 2026-10-07.
- Mori K, Kikuchi H, Obara Y, et al. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. Phytomedicine. 2010;17(14):1082-1085. Opened 2026-10-07.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This page is information, not medical advice. Talk to your doctor or pharmacist about your own situation.